4 12, 2022

Ivermectin, a potential anticancer drug derived from an antiparasitic drug

December 4, 2022|International, Ivermectin, Research, Treatment|

Ivermectin has powerful antitumor effects, including the inhibition of proliferation, metastasis, and angiogenic activity, in a variety of cancer cells. This may be related to the regulation of multiple signaling pathways by ivermectin through PAK1 kinase.

On the other hand, ivermectin promotes programmed cancer cell death, including apoptosis, autophagy […]

2 12, 2022

Miraculous Recovery of Hypoxemic COVID-19 Patients with Ivermectin

December 2, 2022|International, Ivermectin, Research, Treatment|

Unhooking Spike Hemagglutinated Red Blood Cells

The past three years have generated millions of case vignettes of patients with COVID-19 respiratory illness.  The most dramatic cases include critically ill inpatients with severe hypoxemia despite maximum respiratory support.  By far, the most notable cases of survival have occurred with the […]

2 12, 2022

The government’s big lie about ivermectin finally revealed

December 2, 2022|Censorship, Corruption, Doctors, Fatality, Inquiry, International, Ivermectin, Law, Misinformed Media, Politics, Psychology, Research, Treatment|

Joel S. Hirschhorn shares jaw-dropping quote from federal attorney defending FDA in lawsuit

By now millions of Americans well-informed about the pandemic know that the cheap, safe and effective generic medicine ivermectin (IVM) was blocked for wide-scale use from the very beginning by the federal government. It was a […]

1 12, 2022

A prospective, randomized, open-label trial of early versus late povidone-iodine gargling in patients with COVID-19

December 1, 2022|International, Research, Solutions, Treatment|

Abstract

Povidone-iodine (PVP–I) is a broad-spectrum antiseptic reagent that has been used for over 50 years. The purpose of this study is to look into the effect of gargling with PVP–I gargling on virus clearance and saliva infectivity in COVID-19.

A prospective, randomized, open-label trial […]

12 11, 2022

Development of a 2-stage neutraceutical treatment protocol for adults with long-COVID-19 syndrome, exploring underlying pathophysiology and treatment effectiveness

November 12, 2022|Australia, Doctors, Health, Research, Treatment|

Long COVID-19 Treatment Trial

The study has been approved by the Human Research Ethics Commitee EC00436, and is registered at the ANZCTR clinical trial registry: ACTRN12622001204730p

Project explanation and objectives

A large number of people experience long-COVID symptoms persisting for weeks and months after […]